Long Term Care Provider Newsletter
|
Welcome to the Office of Inspector General, Division of Health Care's May 2014 edition of the Long Term Care Provider Newsletter. This newsletter is a valuable vehicle to update you on current events affecting Long Term Care.
Please feel free to share this newsletter with anyone you think would benefit. They may continue receiving this newsletter by joining our mailing list using the link at the bottom. We look forward to serving you through this communication vehicle.
|
Kentucky Makes Significant Progress
|
Reducing Antipsychotic Drug Use in Nursing Homes

The risks of antipsychotic (AP) drug use in the general population have been recognized for decades. While APs are highly effective in treating the behavioral and psychotic symptoms of Schizophrenia, Bi-Polar Disorder and several other psychiatric disorders, they have been less effective in treating the behavioral and psychological symptoms of Alzheimer 's disease and other forms of dementia. The risks posed by APs to frail, elderly individuals living in nursing homes are much more pronounced than similar risks posed to the general population. Indeed, APs have never been approved for treating the symptoms of dementia. Despite this, APs continue to be frequently used to treat nursing home residents.
In early 2012, the Centers for Medicare and Medicaid Services (CMS) announced its intention to reduce the use of AP medications in nursing homes by 15%by the end of that calendar year. The targeted population for reduction consisted of nursing home residents receiving APs for the management of behavioral and psychological symptoms of dementia. Just prior to beginning the CMS Initiative, nation-wide use of APs in nursing homes
was 23.9%; by comparison, Kentucky was 25.98%!
To view an individual facility's antipsychotic quality measure visit the Nursing Home Compare website.
|